MAPT and Alzheimer disease: Our brain proteomic studies (Ojo et al., pers comm) have indicated a distinct TBI mediated neurodegeneration, which shares some overlap with AD pathogenesis in the hTau and PSAPP models, that is not primarily mediated by tau or amyloid pathogenesis in our model.